+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections

Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections

Journal of Immunology 97(1): 64-74

Neutralization and hemagglutination inhibition (HI) tests were compared for sensitivity and specificity, and complement fixation (CF) tests to adenovirus group antigen for sensitivity, in the detection of antibody in individuals with adenovirus isolations. Neutralization tests revealed the highest proportion of significant homo-typic antibody increases (52%) followed by HI tests on Pseudomonas-filtrate-treated sera (48%), HI tests on untreated sera (34 per cent) and HI tests on kaolin-treated sera (30%). CF tests with adenovirus group antigen revealed significant antibody increases in only 38% of the patients, and most of these increases occurred in patients infected with adenovirus type 4, the viral type used for preparation of the antigen. In a number of patients homotypic neutralizing and HI antibody occurred independently of one another. An association was noted between age and production of homotypic neutralizing and HI antibody; antibody was absent in a higher proportion of sera from infants and young children than sera from young adults. Differences were noted in the frequency of occurrence in human sera of nonspecific HA inhibitor for the different adenovirus types, the highest proportion of sera showing inhibitors for adenovirus types 1, 2, 4 and 5, with few showing inhibitor for adenovirus types 3, 7, 10 and 11. Treatment of human sera with filtrates from a psychrophylic Pseudomonas sp. was found to be as effective as kaolin treatment for removal of nonspecific inhibitors of adenovirus hemagglutination, and it showed less tendency to remove specific antibody.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 025066823

Download citation: RISBibTeXText

PMID: 4288350

Related references

Hemagglutination-inhibiting, complement-fixing and neutralizing antibody responses in ECHO 6 infection, including studies on heterotypic responses. Journal of Immunology 88: 47-54, 1962

Comparative Evolution Of Hemagglutination-Inhibiting, Complement-Fixing And Neutralizing Antibodies During An Epidemic Due To Adenovirus 7a. Annales de L'institut Pasteur 108: 180-195, 1965

Rubella antibody studies in the inhabitants of Montreal. Incidence of hemagglutination-inhibiting, complement-fixing and neutralizing antibodies. Canadian Journal of Public Health 60(10): 395-401, 1969

Hemagglutination-inhibiting antibody responses in human infections with group B coxsackieviruses. Journal of Immunology 96(2): 311-318, 1966

Serologic studies of encephalitis in Japan. I. Hemagglutination-inhibiting, complement-fixing, and neutralizing antibody following overt Japanese B encephalitis. Journal of Infectious Diseases 99(2): 155-162, 1956

Neutralizing and Complement Fixing Antibody Response to Adenovirus Infection. Journal of Infectious Diseases 99(2): 199-206, 1956

Neutralizing and complement-fixing antibody response to adenovirus infection. Jour Infect Dis 99(2): 199-206, 1956

Hemagglutination-inhibition antibody responses in human adenovirus infections. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 108: 474-479, 1961

Clinical reactivity and immunogenicity of hemagglutinin influenza vaccine. I. Clinical reactions, hemagglutination-inhibiting and strain and type-specific complement-fixing antibody responses in subjects aged 3-6, 16-17 and 27-50 years. Archiv für die Gesamte Virusforschung 36(1): 43-52, 1972

Comparison of neutralizing and hemagglutination-inhibiting antibody responses for evaluating the seasonal influenza vaccine. Journal of Virological Methods 182(1-2): 43-49, 2012

Neutralizing And Complement-Fixing Antibody Production And Resistance Following Vaccination In Experimental Encephalitis Infections. Journal of Experimental Medicine 78(6): 447-463, 1943

Neutralizing and complement fixing antibody responses in pre exposure and post exposure vaccinees to a rabies vaccine produced in human di ploid cells. Journal of Biological Standardization 4(4): 249-262, 1976

Immunological studies with group B arthropod-borne viruses. VI. Hemagglutination-inhibiting antibody responses to 17D yellow fever vaccine in human subjects with different degrees of complexity of pre-vaccination group B virus experience. American Journal of Tropical Medicine and Hygiene 15(4): 601-610, 1966

Comparison of the hemagglutination-inhibiting and neutralizing antibody responses of volunteers given 400 chick cell-agglutinating units of influenza A/New Jersey/76 split-virus vaccine. Journal of Infectious Diseases 136 Suppl: S472-S474, 1977

A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections. Zeitschrift für Immunitatsforschung, Experimentelle und Klinische Immunologie 141(5): 411-429, 1971